Federal contractor · SAN DIEGO, CA

PLUS THERAPEUTICS, INC.

No contract obligations recorded for PLUS THERAPEUTICS, INC. in FY2026. Since FY2017: $12.5M.

Obligations · FY2026
$0
New awards
0
Sole-source
—
Single offer
—
UEI
NUN2VLR3MZD6
Small business
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 13.4MFY2017
  2. 0FY2020
  3. -818.7KFY2021

Top buying agencies

Obligations in FY2026.

No contract obligations recorded for PLUS THERAPEUTICS, INC. in FY2026.

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

Where the work was performed

Integrity signals

Shares of the year's obligations, next to the country's.

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

PLUS THERAPEUTICS, INC. received $0 in federal assistance in FY2026, on 2 actions (0 new awards).

Assistance · FY2026
$0
New awards
0
Actions
2
Since FY2024
$3M

Assistance by fiscal year

  1. 3MFY2024
  2. 0FY2025
  3. 0FY2026

Largest awards

  1. (NO IDC) DEVELOPMENT OF A NOVEL TARGETED RADIOTHERAPEUTIC FOR THE TREATMENT OF PEDIATRIC HIGH-GRADE GLIOMA (HGG) AND EPENDYMOMA$3M
    12.420 · Military Medical Research and Development· Defense Health Agency· Project grant· Aug 23, 2024 – Jul 29, 2026· HT94252411035

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2024–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026.